Gene · 309
Papers2,188
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 2,188
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CHIP-dependent regulation of the actin cytoskeleton is linked to neuronal cell membrane integrity. | iScience | 2021 | 34401662 | PubTator, text mining | PubMed |
| Suppression of Tumorigenicity 5 Ameliorates Tumor Characteristics of Invasive Breast Cancer Cells via ERK/JNK Pathway. | Front Oncol | 2021 | 34395234 | PubTator, text mining | PubMed |
| IL-10 and IL-12 (P70) Levels Predict the Risk of Covid-19 Progression in Hypertensive Patients: Insights From the BRACE-CORONA Trial. | Front Cardiovasc Med | 2021 | 34386533 | PubTator, text mining | PubMed |
| Peripheral Blood T Cell Gene Expression Responses to Exercise and HMB in Sarcopenia. | Nutrients | 2021 | 34371826 | PubTator, text mining | PubMed |
| SARS-CoV-2 Infection Remodels the Phenotype and Promotes Angiogenesis of Primary Human Lung Endothelial Cells. | Microorganisms | 2021 | 34361874 | PubTator, text mining | PubMed |
| CD14 Expressing Precursors Give Rise to Highly Functional Conventional Dendritic Cells for Use as Dendritic Cell Vaccine. | Cancers (Basel) | 2021 | 34359719 | PubTator, text mining | PubMed |
| Crosstalk between Tumor-Infiltrating Immune Cells and Cancer-Associated Fibroblasts in Tumor Growth and Immunosuppression of Breast Cancer. | J Immunol Res | 2021 | 34337083 | PubTator, text mining | PubMed |
| Role of Extracellular Vesicles in Compromising Cellular Resilience to Environmental Stressors. | Biomed Res Int | 2021 | 34337063 | PubTator, text mining | PubMed |
| Mapping Autoantibodies in Children With Acute Rheumatic Fever. | Front Immunol | 2021 | 34335616 | PubTator, text mining | PubMed |
| Prognoses and genomic analyses of proteasome 26S subunit, ATPase (PSMC) family genes in clinical breast cancer. | Aging (Albany NY) | 2021 | 34329194 | PubTator, text mining | PubMed |
| Phenothiazines alter plasma membrane properties and sensitize cancer cells to injury by inhibiting annexin-mediated repair. | J Biol Chem | 2021 | 34324830 | PubTator, text mining | PubMed |
| Targeting mTOR signaling overcomes acquired resistance to combined BRAF and MEK inhibition in BRAF-mutant melanoma. | Oncogene | 2021 | 34304249 | PubTator, text mining | PubMed |
| Switch to Autophagy the Key Mechanism for Trabecular Meshwork Death in Severe Glaucoma. | Clin Ophthalmol | 2021 | 34285469 | PubTator, text mining | PubMed |
| MARCH8 inhibits influenza A virus infection by targeting viral M2 protein for ubiquitination-dependent degradation in lysosomes. | Nat Commun | 2021 | 34285233 | PubTator, text mining | PubMed |
| Evaluation of In Vitro Phototoxicity of a Minibody-IR700 Conjugate Using Cell Monolayer and Multicellular Tumor Spheroid Models. | Cancers (Basel) | 2021 | 34283089 | PubTator, text mining | PubMed |
| Extracellular Vesicles as Mediators of Cancer Disease and as Nanosystems in Theranostic Applications. | Cancers (Basel) | 2021 | 34283059 | PubTator, text mining | PubMed |
| Possible Therapeutic Strategy Involving the Purine Synthesis Pathway Regulated by ITK in Tongue Squamous Cell Carcinoma. | Cancers (Basel) | 2021 | 34283052 | PubTator, text mining | PubMed |
| Molecular and cellular basis of genetically inherited skeletal muscle disorders. | Nat Rev Mol Cell Biol | 2021 | 34257452 | PubTator, text mining | PubMed |
| Exosomal annexin A6 induces gemcitabine resistance by inhibiting ubiquitination and degradation of EGFR in triple-negative breast cancer. | Cell Death Dis | 2021 | 34238922 | PubTator, text mining | PubMed |
| The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives. | Signal Transduct Target Ther | 2021 | 34219130 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/309/papers?page=26